KappAhl will announce its first quarter results (September - November 2013) Tuesday 14 January at 07.30 (CET). A teleconference will be held on the same day, for analysts, media and investors, at 09.00 (CET). The report will be presented by Johan Åberg, President and CEO and Anders Düring, CFO. The presentation will be held in English and will also be live webcasted at www.kappahl.com/presentations. Questions can be asked via the teleconference or via the webcast. It is also possible to listen to the webcast afterwards at the same address. To participate, please call 5 minutes before the opening of the conference: Sweden +46 (0)8 5055 6477 Great Britain +44 207 660 2077 For further information, please contact: Charlotte Högberg, Head Public Relations, tel +46 704 71 56 31, charlotte.hogberg@kappahl.com Anders Düring, CFO, tel. +46 704 71 55 78, anders.during@kappahl.com KappAhl, founded in 1953, is one of the Nordic region’s leading fashion retailers with close to 400 stores in Sweden, Norway, Finland and Poland, and Shop Online. KappAhl offers value-for-money fashion of its own design to the many people – men, women and children, with a special focus on women in the prime of life. KappAhl was the world’s first fashion retailer to gain environmental certification in 1999. In 2012/2013, sales were SEK 4.8 billion and the number of employees approximately 4,500. KappAhl is quoted on Nasdaq OMX Stockholm. For more information, go to www.kappahl.com. KappAhl AB (publ) discloses the information provided here pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 7 January 2014 at 07.30 a.m.
Invitation to presentation of KappAhl Q1 report 2013/2014
Top 10 Most Recent News Articles
Alaska's Insurance Maze: Coverage Over Cheap Policies
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue Reading
Darden Faces Class Action Over Reimbursement Failures
Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...
Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment
Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....
Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit
Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...
Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026
The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...
Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?
A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...
Continue ReadingTop 5 Most Recently Viewed Articles
Heights Wellness Retreat: A Bold Step Towards Holistic Wellness
Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...
Continue Reading
GeneDx Strengthens Leadership with New COO Appointment
GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...
Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon
FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...
Continue Reading
Empowering Veterans: United Food Group's New Initiative
United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...
Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments
U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...
Continue Reading